CSL Ltd (ASX:CSL) | News, Chart & Analysis

About CSL

CSL is a global biotech supplying medicines for haemophilia and immune deficiencies, influenza vaccines, and iron-deficiency and nephrology therapies.

Explaining ASX Healthcare Shares: Biotechnology To Medical Equipment and Why It Matters To Investors

The healthcare sector has spent much of 2026 going against the expectations associated with it. Healthcare is meant to be the defensive part of the ma...

August 25, 2026 • 0 views

All News for CSL

1 month ago ASX 200

ASX 200 Earnings Season: High-Impact Movers to Watch

More than 250 ASX-listed companies are releasing FY26 results across the five weeks from 3 to 31 August, and the tone of...

ASX Code CSL

Sector Health Care Sector News

Total Articles 1

CSL Ltd

Price Chart

About CSL

Explaining ASX Healthcare Shares: Biotechnology To Medical Equipment and Why It Matters To Investors

All News for CSL

ASX 200 Earnings Season: High-Impact Movers to Watch

Company Stats

CSL Ltd

Price Chart

About CSL

Explaining ASX Healthcare Shares: Biotechnology To Medical Equipment and Why It Matters To Investors

All News for CSL

ASX 200 Earnings Season: High-Impact Movers to Watch

Company Stats

Related Companies

Most Mentioned

Company Alerts